Effect of Prolonged Methylprednisolone Therapy in Unresolving Acute Respiratory Distress Syndrome
Article Abstract:
Prolonged treatment with methylprednisolone may be beneficial in patients with acute respiratory distress syndrome (ARDS). Mortality rates in ARDS patients often exceed 50%. Researchers assigned 16 ARDS patients to receive methylprednisolone treatment for 32 days and 8 ARDS patients to receive a placebo. Methylprednisolone improved lung function and reduced the risk of multiple organ failure. Mortality rates during hospitalization were 62% in the placebo group and 12% in the methylprednisolone group.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Effect of Prolonged Methylprednisolone Therapy in Unresolving Acute Respiratory Distress Syndrome
Article Abstract:
Prolonged treatment with methylprednisolone may be beneficial in patients with acute respiratory distress syndrome (ARDS). Mortality rates in ARDS patients often exceed 50%. Researchers assigned 16 ARDS patients to receive methylprednisolone treatment for 32 days and 8 ARDS patients to receive a placebo. Methylprednisolone improved lung function and reduced the risk of multiple organ failure. Mortality rates during hospitalization were 62% in the placebo group and 12% in the methylprednisolone group.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
User Contributions:
Comment about this article or add new information about this topic: